Journal profile · BIOCHEMISTRY & MOLECULAR BIOLOGY
Progress in Molecular Biology and Translational Science
ISSN 1877-1173 · Academic Press Inc. · UNITED STATES
Progress in Molecular Biology and Translational Science: impact factor 2.12; subscription journal; review 4–8 weeks (community reports); community-reported acceptance: fairly easy; 147 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Progress in Molecular Biology and Translational Science is published by Academic Press Inc.. By OpenAlex counts of its recent articles, its largest topics are CRISPR and Genetic Engineering, Receptor Mechanisms and Signaling and Epigenetics and DNA Methylation, together about 24.1% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Progress in Molecular Biology and Translational Science (PMBTS) provides in-depth reviews on topics of exceptional scientific importance. If today you read an Article or Letter in Nature or a Research Article or Report in Science reporting findings of exceptional importance, you likely will find comprehensive coverage of that research area in a future PMBTS volume.
Source: LetPub
Research area (LetPub): BIOCHEMISTRY & MOLECULAR BIOLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology9.1%
- Receptor Mechanisms and SignalingBiochemistry, Genetics and Molecular Biology9%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology6%
- Alzheimer's disease research and treatmentsMedicine5.6%
- Neuropeptides and Animal PhysiologyNeuroscience4.6%
- RNA and protein synthesis mechanismsBiochemistry, Genetics and Molecular Biology4.1%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology3.9%
- Protein Structure and DynamicsBiochemistry, Genetics and Molecular Biology3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.12LetPub ·
- CiteScore 2026-06
- 5LetPub ·
- CiteScore (publisher)
- 5Publisher website ·
- SJR 2026-06
- 0.38LetPub ·
- SNIP 2026-06
- 0.25LetPub ·
- h-index
- 88LetPub ·
- h-index
- 107OpenAlex ·
- i10-index
- 1,034OpenAlex ·
- 2-year mean citedness
- 1.43OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 86LetPub ·
Articles by year OpenAlex count · 2,432 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 143 | 4 | 28 |
| 2025 | 147 | 5 | 156 |
| 2024 | 167 | 3 | 469 |
| 2023 | 111 | 6 | 496 |
| 2022 | 159 | 10 | 1,732 |
| 2021 | 123 | 2 | 913 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Academic Press Inc.
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 1877-1173
- Official links
- Journal homepage ↗LetPub
FAQ
Frequently asked questions about Progress in Molecular Biology and Translational Science
What is the impact factor of Progress in Molecular Biology and Translational Science?
The latest impact factor listed by LetPub is 2.12; CiteScore 5, h-index 107.
How long does peer review take at Progress in Molecular Biology and Translational Science?
Authors report an average review time of 4–8 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Progress in Molecular Biology and Translational Science?
According to LetPub and DOAJ records, Progress in Molecular Biology and Translational Science is indexed in Scopus.
Is Progress in Molecular Biology and Translational Science open access, and what is the APC?
Progress in Molecular Biology and Translational Science is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .